These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 26925673)

  • 21. Oncogenic Ras, but not (V600E)B-RAF, protects from cholesterol depletion-induced apoptosis through the PI3K/AKT pathway in colorectal cancer cells.
    Calleros L; Sánchez-Hernández I; Baquero P; Toro MJ; Chiloeches A
    Carcinogenesis; 2009 Oct; 30(10):1670-7. PubMed ID: 19700418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ellagic acid prevents rat colon carcinogenesis induced by 1, 2 dimethyl hydrazine through inhibition of AKT-phosphoinositide-3 kinase pathway.
    Umesalma S; Sudhandiran G
    Eur J Pharmacol; 2011 Jun; 660(2-3):249-58. PubMed ID: 21463623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The anti-oncogenic influence of ellagic acid on colon cancer cells in leptin-enriched microenvironment.
    Yousef AI; El-Masry OS; Yassin EH
    Tumour Biol; 2016 Oct; 37(10):13345-13353. PubMed ID: 27460082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Abnormal expression of APRIL in colorectal cancer cells promotes tumor growth and metastasis].
    Wang GH; Lu MH; Wang JC; Wang F; Ding WF; Wang YG; Ju SQ; Wang HM
    Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):249-55. PubMed ID: 23985251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi-targeted kinase inhibitors in pimasertib-resistant human lung and colorectal cancer cells.
    Martinelli E; Troiani T; D'Aiuto E; Morgillo F; Vitagliano D; Capasso A; Costantino S; Ciuffreda LP; Merolla F; Vecchione L; De Vriendt V; Tejpar S; Nappi A; Sforza V; Martini G; Berrino L; De Palma R; Ciardiello F
    Int J Cancer; 2013 Nov; 133(9):2089-101. PubMed ID: 23629727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53/microRNA-374b/AKT1 regulates colorectal cancer cell apoptosis in response to DNA damage.
    Gong H; Cao Y; Han G; Zhang Y; You Q; Wang Y; Pan Y
    Int J Oncol; 2017 May; 50(5):1785-1791. PubMed ID: 28339062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
    McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
    Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncogenic K-ras activates p38 to maintain colorectal cancer cell proliferation during MEK inhibition.
    van Houdt WJ; de Bruijn MT; Emmink BL; Raats D; Hoogwater FJ; Borel Rinkes IH; Kranenburg O
    Cell Oncol; 2010 Jan; 32(4):245-57. PubMed ID: 20413844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The comparison between dual inhibition of mTOR with MAPK and PI3K signaling pathways in KRAS mutant NSCLC cell lines.
    Dogan Turacli I; Ozkan AC; Ekmekci A
    Tumour Biol; 2015 Dec; 36(12):9339-45. PubMed ID: 26108998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel small interfering RNA cotargeting strategy as treatment for colorectal cancer.
    Valentino JD; Elliott VA; Zaytseva YY; Rychahou PG; Mustain WC; Wang C; Gao T; Evers BM
    Surgery; 2012 Aug; 152(2):277-85. PubMed ID: 22828149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The anti-tumourigenic effect of ellagic acid in SKOV-3 ovarian cancer cells entails activation of autophagy mediated by inhibiting Akt and activating AMPK.
    Elsaid FG; Alshehri MA; Shati AA; Al-Kahtani MA; Alsheri AS; Massoud EE; El-Kott AF; El-Mekkawy HI; Al-Ramlawy AM; Abdraboh ME
    Clin Exp Pharmacol Physiol; 2020 Sep; 47(9):1611-1621. PubMed ID: 32415699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
    Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
    Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene expression, cell cycle arrest and MAPK signalling regulation in Caco-2 cells exposed to ellagic acid and its metabolites, urolithins.
    González-Sarrías A; Espín JC; Tomás-Barberán FA; García-Conesa MT
    Mol Nutr Food Res; 2009 Jun; 53(6):686-98. PubMed ID: 19437480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ellagic acid, extracted from Sanguisorba officinalis, induces G1 arrest by modulating PTEN activity in B16F10 melanoma cells.
    Tan YH; Shudo T; Yoshida T; Sugiyama Y; Si JY; Tsukano C; Takemoto Y; Kakizuka A
    Genes Cells; 2019 Nov; 24(11):688-704. PubMed ID: 31495058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypericum androsaemum water extract inhibits proliferation in human colorectal cancer cells through effects on MAP kinases and PI3K/Akt pathway.
    Xavier CP; Lima CF; Fernandes-Ferreira M; Pereira-Wilson C
    Food Funct; 2012 Aug; 3(8):844-52. PubMed ID: 22596086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ADAMTS9 is Silenced by Epigenetic Disruption in Colorectal Cancer and Inhibits Cell Growth and Metastasis by Regulating Akt/p53 Signaling.
    Chen L; Tang J; Feng Y; Li S; Xiang Q; He X; Ren G; Peng W; Xiang T
    Cell Physiol Biochem; 2017; 44(4):1370-1380. PubMed ID: 29186710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ellagic acid: cytodifferentiating and antiproliferative effects in human prostatic cancer cell lines.
    Vanella L; Barbagallo I; Acquaviva R; Di Giacomo C; Cardile V; Abraham NG; Sorrenti V
    Curr Pharm Des; 2013; 19(15):2728-36. PubMed ID: 23092326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Harmine induces cell cycle arrest and mitochondrial pathway-mediated cellular apoptosis in SW620 cells via inhibition of the Akt and ERK signaling pathways.
    Liu J; Li Q; Liu Z; Lin L; Zhang X; Cao M; Jiang J
    Oncol Rep; 2016 Jun; 35(6):3363-70. PubMed ID: 27004568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ellagic acid protects endothelial cells from oxidized low-density lipoprotein-induced apoptosis by modulating the PI3K/Akt/eNOS pathway.
    Ou HC; Lee WJ; Lee SD; Huang CY; Chiu TH; Tsai KL; Hsu WC; Sheu WH
    Toxicol Appl Pharmacol; 2010 Oct; 248(2):134-43. PubMed ID: 20691200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PKI 166 induced redox signalling and apoptosis through activation of p53, MAP kinase and caspase pathway in epidermoid carcinoma.
    Das S; Dey KK; Bharti R; MaitiChoudhury S; Maiti S; Mandal M
    J Exp Ther Oncol; 2012; 10(2):139-53. PubMed ID: 23350354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.